Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

被引:477
|
作者
Mandelblatt, Jeanne S. [1 ]
Cronin, Kathleen A.
Bailey, Stephanie
Berry, Donald A.
de Koning, Harry J.
Draisma, Gerrit
Huang, Hui
Lee, Sandra J.
Munsell, Mark
Plevritis, Sylvia K.
Ravdin, Peter
Schechter, Clyde B.
Sigal, Bronislava
Stoto, Michael A.
Stout, Natasha K.
van Ravesteyn, Nicolien T.
Venier, John
Zelen, Marvin
Feuer, Eric J.
机构
[1] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE;
D O I
10.7326/0003-4819-151-10-200911170-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.
引用
收藏
页码:738 / W247
页数:15
相关论文
共 50 条
  • [41] Communicating the Benefits and Harms of Cancer Screening
    Lindsay J. L. Forbes
    Amanda J. Ramirez
    Current Oncology Reports, 2014, 16
  • [42] On the benefits and harms of screening for breast cancer
    Gotzsche, PC
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2004, 33 (01) : 56 - 64
  • [43] The benefits of screening-and its harms
    Johansson, Minna
    Jorgensen, Karsten Juhl
    Brodersen, John
    LANCET, 2016, 388 (10044): : 563 - 564
  • [44] Communicating the Benefits and Harms of Cancer Screening
    Forbes, Lindsay J. L.
    Ramirez, Amanda J.
    CURRENT ONCOLOGY REPORTS, 2014, 16 (05)
  • [45] The potential harms of over screening
    Rahangdale, L.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (01) : 39 - 39
  • [46] Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses
    Dejana Braithwaite
    Louise C. Walter
    Monika Izano
    Karla Kerlikowske
    Journal of General Internal Medicine, 2016, 31 : 561 - 572
  • [47] Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses
    Braithwaite, Dejana
    Walter, Louise C.
    Izano, Monika
    Kerlikowske, Karla
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 (05) : 561 - 572
  • [48] Health benefits and harms of mammography screening in older women (75+ years)—a systematic review
    Erin Mathieu
    Naomi Noguchi
    Tong Li
    Alexandra L. Barratt
    Jolyn K. Hersch
    Geertruida H. De Bock
    Elizabeth J. Wylie
    Nehmat Houssami
    British Journal of Cancer, 2024, 130 : 275 - 296
  • [49] Health benefits and harms of mammography screening in older women (75+years)-a systematic review
    Mathieu, Erin
    Noguchi, Naomi
    Li, Tong
    Barratt, Alexandra L.
    Hersch, Jolyn K.
    De Bock, Geertruida H.
    Wylie, Elizabeth J.
    Houssami, Nehmat
    BRITISH JOURNAL OF CANCER, 2023, 130 (2) : 275 - 296
  • [50] Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years RESPONSE
    van Ravesteyn, Nicolien T.
    Miglioretti, Diana L.
    Mandleblatt, Jeanne S.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (08) : 597 - 598